Legal & General Group’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Legal & General Group’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,678	Closed	-$168K	–	2826
2015 Q1	$168K	Buy	+1,678	New	+$112K	﹤0.01%	1760

Legal & General Group's ASPX Position: Q2 2015 in Review

Legal & General Group sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 1,678 shares — an estimated $168K sold.

Legal & General Group first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $168K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Legal & General Group reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Legal & General Group sold 1,678 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $168K.
Legal & General Group first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
Legal & General Group's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $168K in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Legal & General Group's 13F filing for Q2 2015, filed 31 Jul 2015.